Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...

Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS ...

Data reinforce dose-dependent mechanism with IMNN-001 100mg/m2 dose associated with 20% increase in IL-12 levels compared to 79mg/m2 dose Results from OVATION 2 Study continue to validate TheraPlas® ...

YourBio Health, a pioneer in remote blood collection technology, announced today the appointments of Michael Mina, M.D., Ph.D. as Chief Scientific Officer, Chester Robson D.O., as Chief Medical ...